Immutopics Didn't Infringe Antibody Patent: Fed. Circ.

Law360, New York (May 10, 2010, 7:17 PM EDT) -- A federal appeals court has upheld Immutopics Inc.'s summary judgment of noninfringement victory in a Scantibodies Laboratory Inc. suit accusing the bone health assay manufacturer of infringing a patent for methods and devices to detect levels of parathyroid hormone in biological samples.

A three-judge panel in the U.S. Court of Appeals for the Federal Circuit on Thursday rejected Scantibodies' argument that the district court erred in construing a claim of the asserted patent, ruling that the plain meaning of the disputed claim “is fully consistent with...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.